NASDAQ Confirms BioSource in Compliance with Listing Requirements
01 7월 2005 - 9:30PM
Business Wire
BioSource International, Inc. (Nasdaq:BIOIE) today announced that
Nasdaq has informed the Company that effective on Tuesday, July 5,
2005, BioSource common stock will once again trade under its
original trading symbol "BIOI." The Company's stock has been
trading under the amended symbol "BIOIE" since May 27, 2005,
subsequent to the Company receiving a notice of delisting
determination due to the delay in filing its periodic report with
the SEC on Form 10-Q for the quarter ended March 31, 2005.
BioSource filed its 2005 first quarter 10-Q on June 28, 2005, and
has received notification from the Nasdaq Office of General
Counsel, Listing Qualifications Hearings confirming compliance with
SEC filing requirements and all other requirements for continued
listing on the Nasdaq National Market. Accordingly, the Company's
delisting hearing has been canceled and the hearing file will be
closed. About BioSource International, Inc. BioSource
International, Inc. is a broad-based life sciences company focused
on providing integrated solutions in the areas of functional
genomics, proteomics, and drug discovery through the development,
manufacturing, marketing, and distribution of unique, biologically
active reagent systems which facilitate, enable, and accelerate
pharmaceutical development and biomedical research. For more
information, please visit the Company's Web site at
www.biosource.com. Statements included in this release that are not
historical facts may be considered forward-looking statements that
are subject to a variety of risks and uncertainties. In addition,
readers are urged to consider statements that include the terms
"believes," "belief," "expects," "plans," "objectives,"
"anticipates," "intends," "targets," "projections," or the like to
be uncertain and forward looking. For these statements, we claim
the safe harbor for "forward-looking statements" within the meaning
of the Private Securities Litigation Reform Act of 1995. Factors
that could cause actual results to differ and vary materially from
the forward-looking statements made herein include, among others,
our ability to expand our product offerings and any transition to
new products, product quality and availability, any change in
business conditions, changes in our sales strategy and product
development plans, competitive pricing pressures, continued market
acceptance of our products, name recognition of our products,
delays in the development of new technology, possible invalidity or
infringement issues related to intellectual property or proprietary
rights, changes in customer buying patterns, one-time events, the
effects of our previously announced process to evaluate strategic
alternatives, including a possible sale of the Company, and any
transaction we may enter into in connection with that process, and
other important factors disclosed previously and from time to time
in our filings with the Securities and Exchange Commission. These
factors should not be construed as exhaustive. We cannot always
predict or determine after the fact what factors would cause actual
results to differ materially from those indicated by the
forward-looking statements or other statements. We do not undertake
any obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future event,
or otherwise.
Biosource (NASDAQ:BIOIE)
과거 데이터 주식 차트
부터 9월(9) 2024 으로 10월(10) 2024
Biosource (NASDAQ:BIOIE)
과거 데이터 주식 차트
부터 10월(10) 2023 으로 10월(10) 2024